- Home
- LHX vs COR Comparison
LHX vs COR Comparison
Compare LHX & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LHX
- COR
- Stock Information
- Founded
- LHX 1895
- COR 2001
- Country
- LHX United States
- COR United States
- Employees
- LHX N/A
- COR N/A
- Industry
- LHX Industrial Machinery/Components
- COR Other Pharmaceuticals
- Sector
- LHX Industrials
- COR Health Care
- Exchange
- LHX Nasdaq
- COR Nasdaq
- Market Cap
- LHX 51.9B
- COR 57.4B
- IPO Year
- LHX N/A
- COR N/A
- Fundamental
- Price
- LHX $285.40
- COR $360.52
- Analyst Decision
- LHX Buy
- COR Buy
- Analyst Count
- LHX 17
- COR 12
- Target Price
- LHX $295.63
- COR $325.08
- AVG Volume (30 Days)
- LHX 1.1M
- COR 1.4M
- Earning Date
- LHX 10-30-2025
- COR 11-05-2025
- Dividend Yield
- LHX 1.68%
- COR 0.67%
- EPS Growth
- LHX 46.76
- COR 5.71
- EPS
- LHX 9.29
- COR 7.96
- Revenue
- LHX $21,740,000,000.00
- COR $321,332,819,000.00
- Revenue This Year
- LHX $3.68
- COR $7.53
- Revenue Next Year
- LHX $6.02
- COR $6.61
- P/E Ratio
- LHX $30.68
- COR $45.26
- Revenue Growth
- LHX 2.83
- COR 9.31
- 52 Week Low
- LHX $193.09
- COR $223.92
- 52 Week High
- LHX $308.12
- COR $362.00
- Technical
- Relative Strength Index (RSI)
- LHX 45.05
- COR 81.01
- Support Level
- LHX $285.78
- COR $335.17
- Resistance Level
- LHX $291.90
- COR $350.46
- Average True Range (ATR)
- LHX 6.06
- COR 7.90
- MACD
- LHX -0.93
- COR 1.94
- Stochastic Oscillator
- LHX 13.22
- COR 96.57
About LHX L3Harris Technologies Inc.
In addition to its legacy software-defined radio franchise, L3Harris Technologies has through a series of acquisitions established franchises producing uncrewed aerial vehicles, sensors, avionics, space-based systems, missiles, and solid rocket motors. It also adapts civilian aircraft for military use and provides military and commercial training services, and maintains the US Federal Aviation Administration's communications infrastructure.
About COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.